130 related articles for article (PubMed ID: 23444509)
1. Benfluorex and cardiac valve disease: long delay in publication.
Prescrire Int; 2013 Feb; 22(135):47. PubMed ID: 23444509
[No Abstract] [Full Text] [Related]
2. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
[TBL] [Abstract][Full Text] [Related]
3. Mitral and aortic valvular disease associated with benfluorex use.
Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I
J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428
[TBL] [Abstract][Full Text] [Related]
4. Valvular heart disease associated with benfluorex.
Gueffet JP; Piriou N; Trochu JN
Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
[No Abstract] [Full Text] [Related]
5. Benfluorex: left heart valve disease very common.
Prescrire Int; 2014 May; 23(149):128. PubMed ID: 24926516
[No Abstract] [Full Text] [Related]
6. Benfluorex: increasing reports of valve disorders.
Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
[TBL] [Abstract][Full Text] [Related]
7. [Valvular heart disease associated with benfluorex].
Rafel Ribera J; Casañas Muñoz R; Anguera Ferrando N; Batalla Sahún N; Castro Cels A; Pujadas Capmany R
Rev Esp Cardiol; 2003 Feb; 56(2):215-6. PubMed ID: 12605770
[TBL] [Abstract][Full Text] [Related]
8. Benfluorex: how many deaths?
Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
[No Abstract] [Full Text] [Related]
9. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
[No Abstract] [Full Text] [Related]
10. Benfluorex: the last chapter of drug-induced valvular heart disease?
Droogmans S; Cosyns B; Van Camp G
Eur J Echocardiogr; 2011 Apr; 12(4):263-4. PubMed ID: 21193483
[No Abstract] [Full Text] [Related]
11. Calcifications in benfluorex-induced valve heart disease: a misknown association.
Plurien F; Bruneval P; Jobic Y; Iung B; Ennezat PV
Cardiology; 2015; 130(2):87-90. PubMed ID: 25614032
[TBL] [Abstract][Full Text] [Related]
12. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209
[TBL] [Abstract][Full Text] [Related]
13. Benfluorex-induced cardiac valve injury.
Acar J
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1243-4; author reply 1245-6. PubMed ID: 23109237
[No Abstract] [Full Text] [Related]
14. Drug-induced valvular heart disease: an update.
Andrejak M; Tribouilloy C
Arch Cardiovasc Dis; 2013 May; 106(5):333-9. PubMed ID: 23769407
[TBL] [Abstract][Full Text] [Related]
15. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of benfluorex on heart valves and pulmonary circulation.
Szymanski C; Andréjak M; Peltier M; Maréchaux S; Tribouilloy C
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):679-86. PubMed ID: 24817577
[TBL] [Abstract][Full Text] [Related]
17. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
[TBL] [Abstract][Full Text] [Related]
18. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
Fournier A; Zureik M
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
[TBL] [Abstract][Full Text] [Related]
19. Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.
Le Ven F; Tribouilloy C; Habib G; Gueffet JP; Maréchaux S; Eicher JC; Blanchard-Lemoine B; Rousseau J; Hénon P; Jobic Y; Etienne Y
Eur J Echocardiogr; 2011 Apr; 12(4):265-71. PubMed ID: 21193484
[TBL] [Abstract][Full Text] [Related]
20. Fenfluramine-like cardiovascular side-effects of benfluorex.
Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
